Progress update on the Kit Yamoyo scale-up in Zambia for the stakeholders who support public health in Zambia. The meeting was held at the CDC offices in Lusaka.
For on-going updates please see: http://colalife.org/status
Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chainColaLife
Presentation given by ColaLife's Simon Berry at the Royal Society of Medicine's 11th Medical Innovations Summit 2015 on 12-Sep-15.
This includes a brief history of ColaLife, the learning from the operational trial in Zambia and progress towards national scale-up.
Considerations in Last Mile Delivery in Access to Medicines – the ColaLife StoryColaLife
Considerations in Last Mile Delivery in Access to Medicines
Out of the box thinking and partnership – the ColaLife Story.
This presentation was given at the 'Access to Medicines' conference hosted by Takeda in Geneva on 25-May-17. It describes how access to diarrhoea treatment was transformed in Zambia.
Diarrhoea is the second biggest infectious killer of under 5 children and yet we know how to treat diarrhoea and the medicine is simple, safe and cheap. The problem is that 99% of diarrhoea cases do not receive the recommended treatment: ORS and Zinc. The last remaining barrier is access.
ColaLife presention to C2MTL | 28-May-2014ColaLife
Keynote presentation given at C2MTL on 28-May-2014.
20 mins, fully annotated.
This gives the brief history of ColaLife, describes the ColaLife Trial in Zambia (COTZ), presents our key findings and describes our strategy for impact.
After dinner speech at the 26th DuPont Packaging Awards, 15-May-14, Wilmington, Delaware, USA.
Download the presentation for the speech narrative that is contained in the notes to the slides.
Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chainColaLife
Presentation given by ColaLife's Simon Berry at the Royal Society of Medicine's 11th Medical Innovations Summit 2015 on 12-Sep-15.
This includes a brief history of ColaLife, the learning from the operational trial in Zambia and progress towards national scale-up.
Considerations in Last Mile Delivery in Access to Medicines – the ColaLife StoryColaLife
Considerations in Last Mile Delivery in Access to Medicines
Out of the box thinking and partnership – the ColaLife Story.
This presentation was given at the 'Access to Medicines' conference hosted by Takeda in Geneva on 25-May-17. It describes how access to diarrhoea treatment was transformed in Zambia.
Diarrhoea is the second biggest infectious killer of under 5 children and yet we know how to treat diarrhoea and the medicine is simple, safe and cheap. The problem is that 99% of diarrhoea cases do not receive the recommended treatment: ORS and Zinc. The last remaining barrier is access.
ColaLife presention to C2MTL | 28-May-2014ColaLife
Keynote presentation given at C2MTL on 28-May-2014.
20 mins, fully annotated.
This gives the brief history of ColaLife, describes the ColaLife Trial in Zambia (COTZ), presents our key findings and describes our strategy for impact.
After dinner speech at the 26th DuPont Packaging Awards, 15-May-14, Wilmington, Delaware, USA.
Download the presentation for the speech narrative that is contained in the notes to the slides.
Organisme de formation professionnel spécialisé dans le secteur du sport et de l’animation recherche un(e) comptable unique pour un remplacement congé maternité.
Shop the HD camcorder collection and record life's
greatest ... Check Shipping & Availability.Bring
broadcast-quality HD video to the palm of your hand
3BHK & 4BHK Apartments for sale in Race Course Area, Bangalore at Nitesh Wimbledon Park
Nitesh Wimbledon Park a luxury residential development located in the heart of Bangalore with enchanting views of the Bangalore Turf Club, has world class amenities like a Swimming Pool, Fitness Centre and a Building Manager.
For MOre....:
https://www.bangalore5.com/2BHK-Apartments-in-Bangalore/
http://bangalore5.com/Flats-purchase-in-Bangalore/
http://bangalore5.com/BMRDA-Approved-Layouts/
Grand Challenges for Disaster ReductionFrancisYee1
The Grand Challenges for Disaster Reduction outlines a ten-year
strategy crafted by the National Science and Technology Council’s
Subcommittee on Disaster Reduction (SDR). It sets forth six Grand
Challenges that, when addressed, will enhance community
resilience to disasters and thus create a more disaster-resilient
Nation. These Grand Challenges require sustained Federal
investment as well as collaborations with state and local
governments, professional societies and trade associations, the
private sector, academia, and the international community to
successfully transfer disaster reduction science and technology
into common use.
To meet these Challenges, the SDR has identified priority science and technology
interagency implementation actions by hazard that build upon ongoing efforts.
Addressing these implementation actions will improve America’s capacity to prevent and
recover from disasters, thus fulfilling our Nation’s commitment to reducing the impacts
of all hazards and enhancing the safety and economic well-being of every individual
and community. This is the wildland fire-specific implementation plan. See also sdr.gov
for other hazard-specific implementation plans.
Presentation to University of Michigan | 19-May-14ColaLife
Presentation to the University of Michigan, 19-May-14, Ann Arbor, Michigan at the invitation of the William Davidson Institute.
Download the presentation for the speech narrative that is contained in the notes to the slides.
Presentation to PATH (Seattle, Washington DC and San Francisco), 23-May-14ColaLife
Presentation to PATH staff on 23-May-14.
Delivered in Seattle with a video link to Washington and audio link to San Francisco.
Download the presentation for the speech narrative that is contained in the notes to the slides.
The role of innovation in augmenting healthcare - the ColaLife StoryColaLife
Presentation given by Simon Berry, CEO, ColaLife, at the Africa Health Extension Summit, 27-28 Nov 2019.
Key themes: why we need innovation in healthcare; what is innovation?; how to ensure innovations have an impact; how to move innovations into the mainstream.
Narrative is provided in the notes.
ColaLife presentation to the ANDi Workshop, Addis Ababa, Jan-15ColaLife
ColaLife presentation to the ANDi Workshop, Addis Ababa, Jan-15. The presentation is just 5 minutes long and has six sections:
1. The scope of our work
2. Our starting point
3. What we did
4. What happened
5. The effects
6. recommendations for ANDi
ColaLife Presentation to the Janssen Global Public Health Team, 26-Aug-15ColaLife
A 40 minute presentation covering the background to ColaLife, the ColaLife trial and progress towards scale-up. The presentation also covers the impacts and their measurement, the ColaLife Innovation Map and the scale-up version of the voucher system.
ColaLife - Cross-sector partnerships - new paradigmsColaLife
Presentation to the Stakeholder Engagement Event at Middlesex University outlining how ColaLife had partnered with the academic sector in our work. 6-Jul-16.
In the 2019 fall semester, I was a student in Professor Scott Hamula's advertising class and was given the opportunity to rebrand any less known/advertised brand. The group that I was a part of chose to rebrand The Original Oatly. Attached below is our final project booklet about our new Advertising Campaign plan for Oatly. This project was a lot of fun and extremely thankful I got to have real life experiences in this class.
Media plan created for Silk Soymilk in my sophomore Advertising class. I was responsible for the design of the book and advertisements (print, television, out-of-home).
Organisme de formation professionnel spécialisé dans le secteur du sport et de l’animation recherche un(e) comptable unique pour un remplacement congé maternité.
Shop the HD camcorder collection and record life's
greatest ... Check Shipping & Availability.Bring
broadcast-quality HD video to the palm of your hand
3BHK & 4BHK Apartments for sale in Race Course Area, Bangalore at Nitesh Wimbledon Park
Nitesh Wimbledon Park a luxury residential development located in the heart of Bangalore with enchanting views of the Bangalore Turf Club, has world class amenities like a Swimming Pool, Fitness Centre and a Building Manager.
For MOre....:
https://www.bangalore5.com/2BHK-Apartments-in-Bangalore/
http://bangalore5.com/Flats-purchase-in-Bangalore/
http://bangalore5.com/BMRDA-Approved-Layouts/
Grand Challenges for Disaster ReductionFrancisYee1
The Grand Challenges for Disaster Reduction outlines a ten-year
strategy crafted by the National Science and Technology Council’s
Subcommittee on Disaster Reduction (SDR). It sets forth six Grand
Challenges that, when addressed, will enhance community
resilience to disasters and thus create a more disaster-resilient
Nation. These Grand Challenges require sustained Federal
investment as well as collaborations with state and local
governments, professional societies and trade associations, the
private sector, academia, and the international community to
successfully transfer disaster reduction science and technology
into common use.
To meet these Challenges, the SDR has identified priority science and technology
interagency implementation actions by hazard that build upon ongoing efforts.
Addressing these implementation actions will improve America’s capacity to prevent and
recover from disasters, thus fulfilling our Nation’s commitment to reducing the impacts
of all hazards and enhancing the safety and economic well-being of every individual
and community. This is the wildland fire-specific implementation plan. See also sdr.gov
for other hazard-specific implementation plans.
Presentation to University of Michigan | 19-May-14ColaLife
Presentation to the University of Michigan, 19-May-14, Ann Arbor, Michigan at the invitation of the William Davidson Institute.
Download the presentation for the speech narrative that is contained in the notes to the slides.
Presentation to PATH (Seattle, Washington DC and San Francisco), 23-May-14ColaLife
Presentation to PATH staff on 23-May-14.
Delivered in Seattle with a video link to Washington and audio link to San Francisco.
Download the presentation for the speech narrative that is contained in the notes to the slides.
The role of innovation in augmenting healthcare - the ColaLife StoryColaLife
Presentation given by Simon Berry, CEO, ColaLife, at the Africa Health Extension Summit, 27-28 Nov 2019.
Key themes: why we need innovation in healthcare; what is innovation?; how to ensure innovations have an impact; how to move innovations into the mainstream.
Narrative is provided in the notes.
ColaLife presentation to the ANDi Workshop, Addis Ababa, Jan-15ColaLife
ColaLife presentation to the ANDi Workshop, Addis Ababa, Jan-15. The presentation is just 5 minutes long and has six sections:
1. The scope of our work
2. Our starting point
3. What we did
4. What happened
5. The effects
6. recommendations for ANDi
ColaLife Presentation to the Janssen Global Public Health Team, 26-Aug-15ColaLife
A 40 minute presentation covering the background to ColaLife, the ColaLife trial and progress towards scale-up. The presentation also covers the impacts and their measurement, the ColaLife Innovation Map and the scale-up version of the voucher system.
ColaLife - Cross-sector partnerships - new paradigmsColaLife
Presentation to the Stakeholder Engagement Event at Middlesex University outlining how ColaLife had partnered with the academic sector in our work. 6-Jul-16.
In the 2019 fall semester, I was a student in Professor Scott Hamula's advertising class and was given the opportunity to rebrand any less known/advertised brand. The group that I was a part of chose to rebrand The Original Oatly. Attached below is our final project booklet about our new Advertising Campaign plan for Oatly. This project was a lot of fun and extremely thankful I got to have real life experiences in this class.
Media plan created for Silk Soymilk in my sophomore Advertising class. I was responsible for the design of the book and advertisements (print, television, out-of-home).
KYTS Programme Final Steering & Learning Group meeting 6-Sep-18ColaLife
Slidedeck to support the KYTS Programme Final Steering & Learning Group meeting on 6-Sep-18.
The KYTS Programme increased availability, access and use of ORS and Zinc therapy for home treatment of diarrhoea in children under 5 via private and public-sector development in Lusaka Province, Zambia
New independent research into seafood buying behaviour around the world shows that consumers are increasingly looking for fish products from a sustainable source, and that ecolabels give credibility to these claims.
The research, conducted on behalf of the Marine Stewardship Council (MSC), is believed to be the world’s largest international survey of sustainable seafood consumption. It questioned more than 9,000 regular seafood buyers from 15 countries across Europe, Asia, Australasia and North America. It repeats similar research undertaken on behalf of the MSC in 2010 and 2012, adding to the growing evidence base used by the MSC to encourage industry, retailers and consumers to make sustainable seafood choices.
Presentation to the International Society for Neglected Tropical Diseases - 1...ColaLife
A description of ColaLife's Operational Trial in Zambia including sales data for the Kit Yamoyo to 25 Jan 2013 and an analysis of the role of private sector partners during the different phases of the project.
Kit Yamoyo design review - how the trial findings influenced the design of the Kit Yamoyo anti-diarrhoea kit used in the subsequent national scale-up in Zambia.
ColaLife | Key milestones - 1985 to Dec-13ColaLife
This timeline highlights some of the key milestones since the birth of the ColaLife idea in 1985 to the end of the trial and move to scale-up in Dec-13.
It focussed on the key people involved and describes how the relationship with The Coca-Cola Company and SABMiller has developed.
Additional milestone:
May 2010
Together, Simon, Jane and Rohit submitted their first proposal to the Clinton Health Access Initiative (CHAI) who were seeking out innovative financing and delivery mechanisms for ACTs under the Affordable Medicines Facility for Malaria (AMFm).
The proposal got to final stages of consideration and reinforced the global interest in and potential of the model.
Correction: Rohit Ramchandani's title at CIDA was Senior Health Advisor, not Public Policy Advisor.
Presentation at the Institution of Mechanical Engineers - Appropriate Healthcare Technologies for Developing Countries - 18 September 2013
This presentation includes the narrative in the notes. Please download it to see these.
The slide deck used for the ColaLife / UNICEF workshop on 21 Jan 2011 in Lusaka. An overview of the workshop can be found here: http://www.colalife.org/2011/01/21/zambia-diary-day-5-visit-2-the-workshop/
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
1. Kit Yamoyo Transition
to Scale (KYTS)
Cooperating Partners’ Meeting
Lusaka, Zambia
20-Oct-15
Simon Berry
CEO and co-founder
simon@colalife.org
colalife.org
2. Rohit Ramchandani
Jane Berry
The other members of the ColaLife team
We have no commercial interest in
anything I am going to describe to you
10. Diarrhoea
19%of infectious disease deaths
Malaria
15%of infectious disease deaths
AIDS
4%
Diarrhoea kills as many children than Malaria and AIDS combined
Source: Liu et al (2015) Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated
systematic analysis. The Lancet.
11. In Zambia 46% of children are stunted (up to 70% in some areas)
18. Early 2012 | Pre-trial focus group work
What we learnt
Litre ORS sachets are too big
Measuring water was an issue
Willingness to pay
Preferred branding
20. Mar 2012 | Finalised the Kit Yamoyo design
Kit Yamoyo
• Attractive
21. Mar 2012 | Finalised the Kit Yamoyo design
Kit Yamoyo
• Attractive
• ORS sachets are 200ml
22. Mar 2012 | Finalised the Kit Yamoyo design
Kit Yamoyo
• Attractive
• ORS sachets are 200ml
• Packaging is also:
• A measuring device for
the water
23. Mar 2012 | Finalised the Kit Yamoyo design
Kit Yamoyo
• Attractive
• ORS sachets are 200ml
• Packaging is also:
• A measuring device for
the water
• A mixing device
24. Mar 2012 | Finalised the Kit Yamoyo design
Kit Yamoyo
• Attractive
• ORS sachets are 200ml
• Packaging is also:
• A measuring device for
the water
• A mixing device
• A storage device (the
soap tray is a lid)
• A cup
26. 60%
Only 60% of
mothers
mixed ORS
correctly
when given
litre sachets.
0
Nobody sold
ORS or Zinc
in the
private
sector.
<1%
of children
received the
correct
treatment
for diarrhoea
7.3km
Was the
average
distance to
ORS.
Sep 2012
Before we started
27. 60%
Only 60% of
mothers
mixed ORS
correctly
when given
litre sachets.
0
Nobody sold
ORS or Zinc
in the
private
sector.
<1%
of children
received the
correct
treatment
for diarrhoea
7.3km
Was the
average
distance to
ORS.
>26k
kits sold into
the two
remote rural
trial areas in
12 months.
Aug 2013
After 12 months
Sep 2012
Before we started
28. 60%
Only 60% of
mothers
mixed ORS
correctly
when given
litre sachets.
0
Nobody sold
ORS or Zinc
in the
private
sector.
<1%
of children
received the
correct
treatment
for diarrhoea
7.3km
Was the
average
distance to
ORS.
>26k
kits sold into
the two
remote rural
trial areas in
12 months.
45%
of children in
trial areas
received
ORS/from
Zinc. Up a
baseline of
<1%.
Aug 2013
After 12 months
Sep 2012
Before we started
29. 60%
Only 60% of
mothers
mixed ORS
correctly
when given
litre sachets.
0
Nobody sold
ORS or Zinc
in the
private
sector.
<1%
of children
received the
correct
treatment
for diarrhoea
7.3km
Was the
average
distance to
ORS.
>26k
kits sold into
the two
remote rural
trial areas in
12 months.
45%
of children in
trial areas
received
ORS/from
Zinc. Up a
baseline of
<1%.
2.4km
The distance
to ORS/Zinc in
the trial areas
was reduced
by two-thirds
from 7.3km to
2.4km.
Aug 2013
After 12 months
Sep 2012
Before we started
30. 60%
Only 60% of
mothers
mixed ORS
correctly
when given
litre sachets.
0
Nobody sold
ORS or Zinc
in the
private
sector.
<1%
of children
received the
correct
treatment
for diarrhoea
7.3km
Was the
average
distance to
ORS.
>26k
kits sold into
the two
remote rural
trial areas in
12 months.
45%
of children in
trial areas
received
ORS/from
Zinc. Up a
baseline of
<1%.
2.4km
The distance
to ORS/Zinc in
the trial areas
was reduced
by two-thirds
from 7.3km to
2.4km.
93%
of Kit Yamoyo
users mixed
ORS correctly.
Only 60% do
when given
1 litre sachets.
Aug 2013
After 12 months
Sep 2012
Before we started
31. 60%
Only 60% of
mothers
mixed ORS
correctly
when given
litre sachets.
0
Nobody sold
ORS or Zinc
in the
private
sector.
<1%
of children
received the
correct
treatment
for diarrhoea
7.3km
Was the
average
distance to
ORS.
>26k
kits sold into
the two
remote rural
trial areas in
12 months.
45%
of children in
trial areas
received
ORS/from
Zinc. Up a
baseline of
<1%.
2.4km
The distance
to ORS/Zinc in
the trial areas
was reduced
by two-thirds
from 7.3km to
2.4km.
93%
of Kit Yamoyo
users mixed
ORS correctly.
Only 60% do
when given
1 litre sachets.
Aug 2013
After 12 months
Sep 2012
Before we started
33. In Zambia, it’s the space in the market, not the space in the crates that is important.
This means we can revisit the packaging to make it cheaper.
Kit Yamoyo
Washing Powder
Eggs
Biscuits
Cola – but not Coca-Cola
Bread
40. Scale-up
Control districts
Trial – Sep-12 to Sep-13
Transition – from Oct-13
Transition districts
Intervention districts
KYTS-ACE – from Feb-15
Progress towards national scale-up
42. Scale-up
Control districts
KYTS-LUSAKA – from Oct-15
Trial – Sep-12 to Sep-13
Transition – from Oct-13
Transition districts
Intervention districts
KYTS-ACE – from Feb-15
Progress towards national scale-up
43. Scale-up
Control districts
KYTS-LUSAKA – from Oct-15
Trial – Sep-12 to Sep-13
Transition – from Oct-13
Transition districts
Intervention districts
KYTS-ACE – from Feb-15
Progress towards national scale-up
45. Campaigning for…
1. 200ml ORS sachets for home use
2. Co-packaging of ORS and Zinc
3. ORS and Zinc as over the counter
medicines
4. People to understand that all our
designs, learning and findings are theirs
to take and use for FREE – we are NOT
promoting a product – we are promoting
a game-changing new approach to
diarrhoea treatment in the home
46. Thank you to the ColaLife funders past and present
Isenberg Family
Charitable Foundation
47. Thank you to the ColaLife funders - current
Isenberg Family
Charitable Foundation
[Presentation description: This presentation describes the progress of UK charity ColaLife from its initial concept to ‘piggyback’ simple medicines, at the ‘last mile’ of distribution in developing countries, through to the results and learning from the 2 year trial in Zambia, to scale-up plans to cover the whole of Zambia and spread designs and learning more widely.]
I also want to recognise my colleagues.
Jane works with me full-time when she hasn’t got Shingles which is the case at the moment. She is my partner in life and ColaLife.
Rohit is based in Canada and works with us part-time. He is our public health adviser and it completing his Doctoral in Public Health at Johns Hopkins University.
I also want to recognise my colleagues.
Jane works with me full-time when she hasn’t got Shingles which is the case at the moment. She is my partner in life and ColaLife.
Rohit is based in Canada and works with us part-time. He is our public health adviser and it completing his Doctoral in Public Health at Johns Hopkins University.
I also want to recognise my colleagues.
Jane works with me full-time when she hasn’t got Shingles which is the case at the moment. She is my partner in life and ColaLife.
Rohit is based in Canada and works with us part-time. He is our public health adviser and it completing his Doctoral in Public Health at Johns Hopkins University.
This is the first observation I mentioned
Against this backdrop, 1 in 5 children didn’t make it to their 5th birthday.
– 25 times higher than here in Europe.
ColaLife wants to make this picture for developing countries look like…
… this one.
Just as shocking as this level of mortality is the fact that diarrhoea, an easily treated condition, is the second biggest killer. It was back in 1985 and still now.
Dehydration from diarrhoea kills more children than Malaria and HIV/AIDS combined.
Just as shocking as this level of mortality is the fact that diarrhoea, an easily treated condition, is the second biggest killer. It was back in 1985 and still now.
Dehydration from diarrhoea kills more children than Malaria and HIV/AIDS combined.
Against this backdrop of high mortality and the lack of essential medicines to treat diarrhoea, you can get a Coca-Cola (and other FMCGs) in most places,
While community shops are well stocked with the things people want, the public sector struggles to keep public health centres stocked with essential medicines.
This brings me to the idea…
Coca-Cola get everywhere so if we put medicines in the crates that would get everywhere too.
This brings me to the idea…
This was perhaps our most important activity in the whole trial – talking to mothers about diarrhoea treatment in the home.
We learned four key things:
Litre sachets are too big
Measuring water is problem
We also got an indication of how much they might pay for an anti-diarrhoea kit
And how they’d like it branded
This is the resulting product – Kit Yamoyo – is:
• attractive – aspirational even
• it contains 200ml sachets of ORS
• the packaging acts as a measure for the water
• it’s also a mixing device for the ORS
• and can be used as a cup
Thanks to DfID funding we will start scale-up where most people live - over 2 million of Zambia’s 13 million people live here.
As the final step to national scale-up we will seek support to develop the market in the Copperbelt (green circle) where another 2 milllion live.
So it’s no wonder that diarrhoea holds its position as the 2nd biggest killer of under 5 children.
So what happened during our 12-month trial?
• From a standing start we sold 26,000 kits to retailers serving the trial communities
So what happened during our 12-month trial?
• We increased treatment rates from <1% to 45%
So what happened during our 12-month trial?
• We reduced the distance mothers had to travel to access treatment – shops are a lot closer to people’s homes that clinics
So what happened during our 12-month trial?
• And through the design of the kit we increased correct measurement of the ORS from 60% to 93%. When using Kit Yamoyo, 93% of mothers got the mixing right
Before and after…
But here’s the shock:
• Only 4% of the 26,000 kits sold travelled to the village in Coca-Cola crates
In practice, this is what happened.
It wasn’t the space in the crates that was important, it was the space in the market. We had designed and marketed an aspirational product (just like Coke) which people wanted and which retailers could make a profit bring to the communities and selling (just like Coke).
We design and product TOGETHER WITH its value chain.
The Kit Yamoyo has captured people’s imagination and won many global health, design and innovation awards.
In Sep-13 it was featured at the UN General Assembly as a breakthrough innovation in Child Health.
In Mar-14 it was show-cased by PATH and PSI in their Best Buys for Global Health initiative.
Thanks to DfID funding we will start scale-up where most people live - over 2 million of Zambia’s 13 million people live here.
As the final step to national scale-up we will seek support to develop the market in the Copperbelt (green circle) where another 2 milllion live.
Because the kit no longer needs to fit in Coca-Cola crates we can move to cheaper packaging options.
In the scale-up we will be using two new packaging formats:
• a screw-top
• a flexible pack
Because the kit no longer needs to fit in Coca-Cola crates we can move to cheaper packaging options.
In the scale-up we will be using two new packaging formats:
• a screw-top
• a flexible pack
Because the kit no longer needs to fit in Coca-Cola crates we can move to cheaper packaging options.
In the scale-up we will be using two new packaging formats:
• a screw-top
• a flexible pack
Thanks to DfID funding we will start scale-up where most people live - over 2 million of Zambia’s 13 million people live here.
As the final step to national scale-up we will seek support to develop the market in the Copperbelt (green circle) where another 2 milllion live.
Because the kit no longer needs to fit in Coca-Cola crates we can move to cheaper packaging options.
In the scale-up we will be using two new packaging formats:
• a screw-top
• a flexible pack
Thanks to DfID funding we will start scale-up where most people live - over 2 million of Zambia’s 13 million people live here.
As the final step to national scale-up we will seek support to develop the market in the Copperbelt (green circle) where another 2 milllion live.
Thanks to DfID funding we will start scale-up where most people live - over 2 million of Zambia’s 13 million people live here.
As the final step to national scale-up we will seek support to develop the market in the Copperbelt (green circle) where another 2 milllion live.
And at the same time we are campaigning for:
The production of 200ml ORS sachets for treatment of diarrhoea in the home – we don’t care who produces them – we just want them to be produced and available on the market.
The co-packaging of ORS and Zinc to improve the likelihood that they are dispensed together
ORS and Zinc to be classified as over the counter medicines. They are in many places but not everywhere. This classification will mean that the all pervasive FMCG distribution channels will be open to co-packaged ORS and Zinc
People to understand that ColaLife is not selling anything! We want to give all our designs, learning and findings away for others to exploit for free. We are not selling a product or ideas, we are promoting a game-changing approach to diarrhoea treatment in the home
It was the early commitment of funds to the ColaLife idea that leveraged all the other support for the trial and subsequent to the trial additional funders have come on-board. Notably Ceniarth and the Isenberg Family Charitable Foundation have provided ‘catalytic’ funding and we have always enjoyed support from individual supporters.
It was the early commitment of funds to the ColaLife idea that leveraged all the other support for the trial and subsequent to the trial additional funders have come on-board. Notably Ceniarth and the Isenberg Family Charitable Foundation have provided ‘catalytic’ funding and we have always enjoyed support from individual supporters.